JP2008546732A5 - - Google Patents

Download PDF

Info

Publication number
JP2008546732A5
JP2008546732A5 JP2008517435A JP2008517435A JP2008546732A5 JP 2008546732 A5 JP2008546732 A5 JP 2008546732A5 JP 2008517435 A JP2008517435 A JP 2008517435A JP 2008517435 A JP2008517435 A JP 2008517435A JP 2008546732 A5 JP2008546732 A5 JP 2008546732A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008517435A
Other versions
JP2008546732A (ja
Filing date
Publication date
Priority claimed from PCT/EP2005/012075 external-priority patent/WO2006050959A2/en
Application filed filed Critical
Priority claimed from PCT/EP2006/006097 external-priority patent/WO2006136450A2/en
Publication of JP2008546732A publication Critical patent/JP2008546732A/ja
Publication of JP2008546732A5 publication Critical patent/JP2008546732A5/ja
Pending legal-status Critical Current

Links

JP2008517435A 2005-06-23 2006-06-23 多価化合物 Pending JP2008546732A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP05013594 2005-06-23
EP05020035 2005-09-14
PCT/EP2005/012075 WO2006050959A2 (en) 2004-11-10 2005-11-10 Molecules which promote hematopoiesis
EP05028310 2005-12-24
US78056806P 2006-03-09 2006-03-09
EP06004833 2006-03-09
US74751506P 2006-05-17 2006-05-17
EP06010174 2006-05-17
PCT/EP2006/006097 WO2006136450A2 (en) 2005-06-23 2006-06-23 Supravalent compounds

Publications (2)

Publication Number Publication Date
JP2008546732A JP2008546732A (ja) 2008-12-25
JP2008546732A5 true JP2008546732A5 (ja) 2009-07-30

Family

ID=40239691

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008517435A Pending JP2008546732A (ja) 2005-06-23 2006-06-23 多価化合物

Country Status (7)

Country Link
US (1) US20100145006A1 (ja)
EP (1) EP1907417A2 (ja)
JP (1) JP2008546732A (ja)
CA (1) CA2648732A1 (ja)
EA (1) EA200800109A1 (ja)
IL (1) IL188153A0 (ja)
WO (1) WO2006136450A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009529509A (ja) * 2006-03-09 2009-08-20 アプラゲン ゲーエムベーハー 造血を促進する修飾分子
FI119513B (fi) * 2007-03-07 2008-12-15 Dextech Medical Ab Muokatut hydroksipolymeerikonjugaatit, joilla on tappava vaikutus tuumorisoluihin
EP2216049A1 (en) * 2009-02-06 2010-08-11 Freie Universität Berlin Drug conjugates with polyglycerols
EP2268315B1 (en) * 2008-03-31 2019-07-31 Freie Universität Berlin Drug conjugates with polyglycerols
WO2011012306A2 (en) 2009-07-30 2011-02-03 Aplagen Gmbh Use of emps for antagonising epo-stimulatory effects on epo-responsive tumors while maintaining erythropoiesis
WO2011098095A1 (en) * 2010-02-09 2011-08-18 Aplagen Gmbh Peptides binding the tpo receptor
SG192856A1 (en) 2011-03-04 2013-09-30 Intrexon Corp Vectors conditionally expressing protein

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1055932A (en) * 1975-10-22 1979-06-05 Hematech Inc. Blood substitute based on hemoglobin
CA1304886C (en) * 1986-07-10 1992-07-07 Heinz Dobeli Metal chelate resins
US5047513A (en) * 1986-07-10 1991-09-10 Hoffmann-La Roche Inc. Metal chelate resins
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
US5919758A (en) * 1994-03-22 1999-07-06 Beth Israel Deaconess Medical Center Modified polypeptides with altered biological activity
US5747446A (en) * 1994-03-22 1998-05-05 Beth Israel Deaconess Medical Center Modified polypeptides with increased biological activity
US5767078A (en) * 1995-06-07 1998-06-16 Johnson; Dana L. Agonist peptide dimers
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
KR100459984B1 (ko) * 1995-06-07 2005-06-20 아피맥스 테크놀로지스, 엔.브이. 에리트로포이에틴수용체(epo-r)에결합하는화합물및펩티드
ATE390439T1 (de) * 1995-06-07 2008-04-15 Glaxo Group Ltd An einem thrombopoietin rezeptor bindende peptide und zusammensetzungen
US6251864B1 (en) * 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6187564B1 (en) * 1997-07-10 2001-02-13 Beth Israel Deaconess Medical Center DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
ES2422231T3 (es) * 1998-10-23 2013-09-09 Kirin Amgen Inc Péptidos miméticos de trombopoyetina diméricos que se unen al receptor MP1 y que tienen actividad trombopoyética
US6660843B1 (en) * 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
JO2291B1 (en) * 1999-07-02 2005-09-12 اف . هوفمان لاروش ايه جي Erythropoietin derivatives
AU2003256336A1 (en) * 2002-06-28 2004-01-19 Centocor, Inc. Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
KR20060028675A (ko) * 2003-05-12 2006-03-31 아피맥스, 인크. 신규한 폴리 (에틸렌 글리콜) 개질 화합물 및 그의 용도
EP1812461A2 (en) * 2004-11-10 2007-08-01 AplaGen GmbH Molecules which promote hematopoiesis

Similar Documents

Publication Publication Date Title
JP2008546732A5 (ja)
AT504380A8 (ja)
CN300730300S (zh) 标贴（23）
CN300725917S (zh) 童装(3734)
CN300726012S (zh) 鞋帮
CN300727645S (zh) 电视机(d10-3)
CN300725944S (zh) 童装(3890)
CN300725943S (zh) 童装(3876)
CN300725942S (zh) 童装(3874)
CN300727320S (zh) 摩托车大货架
CN300725941S (zh) 童装(3872)
CN300725940S (zh) 童装(3870)
CN300725939S (zh) 童装裤子(3856)
CN300725938S (zh) 童装(3854)
CN300725937S (zh) 童装(3852)
CN300725936S (zh) 童装(3850)
CN300727187S (zh) 化妆品容器按钮
CN300731882S (zh) 置物架(da002ss)
CN300731711S (zh) 蒸汽加压咖啡制造机
CN300725913S (zh) 童装(3712)
CN300725935S (zh) 童装裤子(3835)
CN300725934S (zh) 童装(3833)
CN300725933S (zh) 童装(3831)
CN300725932S (zh) 童装(3829)
CN300725931S (zh) 童装(3815)